+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease



The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease



Alimentary Pharmacology and Therapeutics 23(6): 743-749



Aspirin is often used in patients with cardiovascular disease, but it can also cause gastrointestinal complications. Proton pump inhibitors reduce the risk of gastrointestinal complications in aspirin users with a history of gastrointestinal complications. To determine the prevalence of gastrointestinal risk factors in aspirin users and the prevalence of proton pump inhibitor utilization in high-risk patients. We reviewed all patients admitted to hospital between April and October 2004 with a diagnosis of cardiovascular disease. We collected data on demographics, medication use, comorbid illnesses, previous gastrointestinal complications, and medication use on admission and discharge. A total of 324 patients were admitted with cardiovascular disease of whom 94% were discharged on aspirin. Seventy-eight per cent of patients admitted had at least one gastrointestinal risk factor in addition to having cardiovascular disease, and 15% had three or more additional gastrointestinal risk factors. Patients with additional gastrointestinal risk factors were more likely to be prescribed proton pump inhibitor therapy (27% vs. 10%, P < 0.001). Only 10% of proton pump inhibitor-naĆ­ve high-risk aspirin users were prescribed a proton pump inhibitor upon discharge. The majority of high-risk aspirin users are not receiving proton pump inhibitors for gastroprotection. Further work is required to encourage providers to consider the use of gastroprotective strategies in appropriate patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 012672551

Download citation: RISBibTeXText

PMID: 16556176

DOI: 10.1111/j.1365-2036.2006.02829.x


Related references

Prevalence of cardiovascular risk factors and concentration of C-reactive protein in Type D personality persons without cardiovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation 18(3): 504-509, 2012

Cardiovascular disease prevalence and risk factors of persons with mental retardation. Mental Retardation and Developmental Disabilities Research Reviews 12(1): 3-12, 2006

Risk factors for hospitalized gastrointestinal bleeding among older persons. Journal of the American Geriatrics Society 49(2): 126-133, 2001

Prevalence of cardiovascular diseases and cardiovascular risk factors in older than 65 years persons in an urban area: DERIVA study. Atencion Primaria 45(7): 349-357, 2014

Health inequalities and the impact on the prevalence of cardiovascular risk factors and chronic complications in Argentina: a study on national risk factors surveys. Medwave 17(9): E7083, 2018

Prevalence of Chronic Complications, Their Risk Factors, and the Cardiovascular Risk Factors among Patients with Type 2 Diabetes Attending the Diabetic Clinic at a Tertiary Care Hospital in Sri Lanka. Journal of Diabetes Research 2018: 4504287, 2018

Prevalence of Hypertension (HTN) and Cardiovascular Risk Factors in a Hospitalized Pediatric Hemophilia Population. Journal of Pediatric Hematology/Oncology 40(3): 196-199, 2017

Prevalence of cardiovascular risk factors of elderly persons in Taiwan. Kaohsiung Journal of Medical Sciences 18(2): 53-61, 2002

Prevalence of risk factors for cardiovascular diseases in aged persons. Vojnosanitetski Pregled 55(4): 401-405, 1998

Racial differences in the prevalence of cardiovascular risk factors among persons with diabetes. Missouri Medicine 90(12): 751-754, 1993

Left ventricular hypertrophy in Type 1 diabetes Prevalence and relation to coronary heart disease and cardiovascular risk factors The EURODIAB IDDM Complications Study Group. Diabetologia 46(Supplement 2): A116, 2003

Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study. Diabetes Care 28(9): 2255-2257, 2005

Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 125(11): 1367-1380, 2012

W1925 Gastroprotection in Patients At Risk of Gastrointestinal Nsaid Complications : Results of a General Practitioner Based Survey in France. Gastroenterology 134(4): A-735, 2008

Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox. Trends in Cardiovascular Medicine 25(8): 705-706, 2016